Faron Pharmaceuticals Oy
LSE:FARN
Faron Pharmaceuticals Oy
Net Income (Common)
Faron Pharmaceuticals Oy
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy
LSE:FARN
|
Net Income (Common)
-€30.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Faron Pharmaceuticals Oy's Net Income (Common)?
Net Income (Common)
-30.9m
EUR
Based on the financial report for Dec 31, 2023, Faron Pharmaceuticals Oy's Net Income (Common) amounts to -30.9m EUR.
What is Faron Pharmaceuticals Oy's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-9%
Over the last year, the Net Income (Common) growth was -8%. The average annual Net Income (Common) growth rates for Faron Pharmaceuticals Oy have been -22% over the past three years , -9% over the past five years .